Impact of Microenvironment in Therapy-Induced Neovascularization of Glioblastoma | OMICS International | Abstract
ISSN: 2168-9652

Biochemistry & Physiology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Impact of Microenvironment in Therapy-Induced Neovascularization of Glioblastoma

Bhagelu R. Achyut*
Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Health System, USA
*Corresponding Author : Bhagelu R. Achyut
Cellular and Molecular Imaging Laboratory
Department of Radiology, Henry Ford Health System
1 Ford Place, 2F, Detroit, MI 48202, USA
Tel: 313-874-4485
Fax: 313-874-4494
E-mail: [email protected]
Received November 26, 2013; Accepted November 26, 2013; Published November 29, 2013
Citation: Achyut BR (2013) Impact of Microenvironment in Therapy-Induced Neovascularization of Glioblastoma. Biochem Physiol 2:e121. doi:10.4172/2168-9652.1000e121
Copyright: © 2013 Achyut BR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Therapy induced neovascularization is an emerging cancer hallmark, which has been observed during the antiangiogenic treatments (AATs) to suppress angiogenesis in glioblastoma and other cancers. Clinicians and researchers have following major questions such as (1) why the AATs are inducing unwanted vasculature? (2) What are the molecular mechanisms associated with this daunting outcome? (3) What are signature targets to combat tumor angiogenesis or vasculogenesis? Focused strategies to investigate these aforementioned questions are required to answer to proceed further. Recent studies have shown the importance of microenvironment in the regulation of angiogenesis and/or neovascularization both at cellular and molecular levels. Better agents with broad range of targets could help to reprogram the tumor microenvironment as well as to combat the tumor and therapy induced neovascularization.